As of 2024-10-14, the Intrinsic Value of Merck & Co Inc (MRK) is
45.11 USD. This Merck valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 109.69 USD, the upside of Merck & Co Inc is
-58.90%.
The range of the Intrinsic Value is 22.64 - 184.62 USD
45.11 USD
Intrinsic Value
Merck Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
22.64 - 184.62 |
45.11 |
-58.9% |
| DCF (Growth 10y) |
43.90 - 299.36 |
79.46 |
-27.6% |
| DCF (EBITDA 5y) |
24.60 - 47.21 |
35.24 |
-67.9% |
| DCF (EBITDA 10y) |
38.17 - 69.83 |
52.67 |
-52.0% |
| Fair Value |
30.86 - 30.86 |
30.86 |
-71.87% |
| P/E |
21.55 - 170.15 |
81.11 |
-26.1% |
| EV/EBITDA |
60.72 - 114.18 |
86.77 |
-20.9% |
| EPV |
44.06 - 58.56 |
51.31 |
-53.2% |
| DDM - Stable |
81.63 - 501.01 |
291.32 |
165.6% |
| DDM - Multi |
33.00 - 149.90 |
53.28 |
-51.4% |
Merck Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
278,043.30 |
| Beta |
0.36 |
| Outstanding shares (mil) |
2,534.81 |
| Enterprise Value (mil) |
304,527.30 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.81% |
| Cost of Debt |
4.25% |
| WACC |
6.43% |